HORIZON-HLTH-2023-DISEASE-03-04
HORIZON-HLTH-2023-DISEASE-03-04
Programme: Horizon Europe
6 projects · €44,860,763 total EU contribution (project-level) · 71 participating organizations · 17 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€44,860,763
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (12)
- France (10)
- Italy (9)
- BE (7)
- CH (6)
- Spain (5)
- Netherlands (5)
- CZ (3)
- PT (3)
- UK (3)
- HU (2)
- AT (1)
- HR (1)
- IE (1)
- LV (1)
- SE (1)
- SK (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- CSIC3 projects · ES
- INSERM3 projects · FR
- CNRS2 projects · FR
- ERASMUS MC2 projects · NL
- ERINHA2 projects · BE
- FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE2 projects · PT
- KU Leuven2 projects · BE
- Leiden University Medical Center1 projects · NL
- LEITAT1 projects · ES
- AFFILOGIC1 projects · FR
- Catalyze B.V.1 projects · NL
- CISTIM LEUVEN1 projects · BE
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
New AntiVirals for Infections with Pandemic Potential NAVIPP · 101137506 | HORIZON | €6,170,153 | €400,886 | Details |
enhanced manufacturing of broadly potent equine polyclonal Fab with a Rational Immunization strategy against Coronaviruses e-FabRIC · 101137157 | HORIZON | €7,666,549 | €1,795,773 | Details |
Antivirus Pandemic Preparedness EuropeAn pLatform APPEAL · 101137311 | HORIZON | €7,565,674 | €1,714,516 | Details |
Evolvable and rapidly adaptable monobodies: a broad-spectrum antiviral platform EvaMobs · 101137419 | HORIZON | €7,999,839 | €314,486 | Details |
Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases AVITHRAPID · 101137192 | HORIZON | €7,459,254 | €300,000 | Details |
Developing broad-spectrum antiviral drugs for pandemic preparedness PANVIPREP · 101137229 | HORIZON | €7,999,295 | €398,735 | Details |